Curcolonol suppresses the motility of breast cancer cells by inhibiting LIM kinase 1 to downregulate cofilin 1 phosphorylation

  • Authors:
    • Hong Lu
    • Jie Chen
    • Yongming Luo
    • Huanjun Xu
    • Ling Xiong
    • Jianjiang Fu
  • View Affiliations

  • Published online on: October 10, 2018     https://doi.org/10.3892/ijo.2018.4592
  • Pages: 2695-2704
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Curcolonol (CCL) is a furan type sesquiterpene isolated from several medical herbs. Based on previous results of anti-migratory activity screening, in this study, we investigated the effects of CCL on cancer cell motility. By in vitro migration assay, we found that CCL significantly inhibited the vertical and horizontal migration of breast cancer cells induced by transforming growth factor (TGF)-β1. In addition, CCL also exerted inhibitory effects on F-actin polymerization in breast cancer cells when the cells were dyed with phalloidin. Given the close association between F-actin and ADF/cofilin, the effects of CCL on the expression and phosphorylation of cofilin 1 were explored. It was observed that there were minimal changes in the expression of cofilin 1; however, the phosphorylation of cofilin 1 was significantly inhibited by CCL in a dose-dependent manner. Furthermore, CCL significantly inhibited the activity of LIM kinase 1 (LIMK1), although almost no effects were observed on LIMK1 expression and phosphorylation. However, the inhibitory effects of CCL on LIMK1 activity were antagonized and enhanced by the overexpression and knockdown of LIMK1, respectively. Based on the current data, it is thus suggested that the suppressive effects of CCL on breast cancer cell motility are due to its potential to reduce the phosphorylation of cofilin 1, which may be associated with the inhibition of the catalytic activity of LIMK1.
View Figures
View References

Related Articles

Journal Cover

December-2018
Volume 53 Issue 6

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lu H, Chen J, Luo Y, Xu H, Xiong L and Fu J: Curcolonol suppresses the motility of breast cancer cells by inhibiting LIM kinase 1 to downregulate cofilin 1 phosphorylation. Int J Oncol 53: 2695-2704, 2018
APA
Lu, H., Chen, J., Luo, Y., Xu, H., Xiong, L., & Fu, J. (2018). Curcolonol suppresses the motility of breast cancer cells by inhibiting LIM kinase 1 to downregulate cofilin 1 phosphorylation. International Journal of Oncology, 53, 2695-2704. https://doi.org/10.3892/ijo.2018.4592
MLA
Lu, H., Chen, J., Luo, Y., Xu, H., Xiong, L., Fu, J."Curcolonol suppresses the motility of breast cancer cells by inhibiting LIM kinase 1 to downregulate cofilin 1 phosphorylation". International Journal of Oncology 53.6 (2018): 2695-2704.
Chicago
Lu, H., Chen, J., Luo, Y., Xu, H., Xiong, L., Fu, J."Curcolonol suppresses the motility of breast cancer cells by inhibiting LIM kinase 1 to downregulate cofilin 1 phosphorylation". International Journal of Oncology 53, no. 6 (2018): 2695-2704. https://doi.org/10.3892/ijo.2018.4592